Cargando…
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
Recent studies have found that cannabinoids may improve neuropsychological performance, ameliorate negative symptoms, and have antipsychotic properties for a subgroup of the schizophrenia population. These findings are in contrast to the longstanding history of adverse consequences of cannabis use,...
Autores principales: | Coulston, Carissa M., Perdices, Michael, Henderson, Antony F., Malhi, Gin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428612/ https://www.ncbi.nlm.nih.gov/pubmed/22937266 http://dx.doi.org/10.1155/2011/501726 |
Ejemplares similares
-
Special Issue: Therapeutic Potential for Cannabis and Cannabinoids
por: Raup-Konsavage, Wesley M.
Publicado: (2023) -
An Investigation of Neurochemical Changes in Chronic Cannabis Users
por: Newman, Sharlene D., et al.
Publicado: (2019) -
Neurochemical and Immunologic Components in Schizophrenia
por: Giller, Earl
Publicado: (1979) -
Cannabis, cannabinoids, and health
por: Lafaye, Genevieve, et al.
Publicado: (2017) -
Cannabis and cannabinoids for mental health indications: evidence of effect and adverse events
por: Bramness, J. G.
Publicado: (2023)